269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群
[臨床試験数:20,薬物数:26(DrugBank:10),標的遺伝子数:12,標的パスウェイ数:90

Searched query = "Pyogenic arthritis", "Pyoderma gangrenosum", "Acne syndrome", "PAPA syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03971643
(ClinicalTrials.gov)
May 16, 201928/5/2019Exploratory Study of IFX-1 in Subjects With Pyoderma GangrenosumOpen Label Exploratory Phase 2a Trial to Investigate the Safety and Efficacy of IFX-1 in Treating Subjects With Pyoderma Gangrenosum (Optima)Pyoderma GangrenosumDrug: IFX-1InflaRx GmbHInnovaderm Research Inc.Recruiting18 YearsN/AAll18Phase 2United States;Canada